Jeff Fairman

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Clostridium Difficile

Inflammatory Response

Endothelial Cells

Coronavirus Disease

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Girmay Desalegn, Chitradevi S Tamilselvi, Jose M Lemme-Dumit, Shannon J Heine, Dylan Dunn, Esther Ndungo, Neeraj Kapoor, Edwin V Oaks, Jeff Fairman, Marcela F Pasetti
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate. NPJ vaccines 9 (1) (2024)
Girmay Desalegn, Chitradevi S Tamilselvi, Jose M Lemme-Dumit, Shannon J Heine, Dylan Dunn, Esther Ndungo, Neeraj Kapoor, Edwin V Oaks, Jeff Fairman, Marcela F Pasetti
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate. NPJ vaccines 9 (1) (2024)
Girmay Desalegn, Chitradevi S Tamilselvi, Jose M Lemme-Dumit, Shannon J Heine, Dylan Dunn, Esther Ndungo, Neeraj Kapoor, Edwin V Oaks, Jeff Fairman, Marcela F Pasetti
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate. NPJ vaccines 9 (1) (2024)
Peter Radvak, Hyung-Joon Kwon, Martina Kosikova, Uriel Ortega-Rodriguez, Ruoxuan Xiang, Je-Nie Phue, Rong-Fong Shen, James Rozzelle, Neeraj Kapoor, Taylor Rabara, Jeff Fairman, Hang Xie
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains. Nature communications 12 (1) (2021)